In our present study, the action of the adiponectin gene (ADIPOQ) promoter SNP −11391 G/A (rs17300539) has been demonstrated on the risk of metabolic syndrome presence, insulin resistance, hypertriglyceridemia, and low serum adiponectin levels in Caucasian patients with obesity. This evidence concerns the gene ADIPOQ and metabolic syndrome.